Simplify's take
What believers are saying
- The ALBORADA Trust committed £9 million on 6 November 2026 for career fellows.
- Three AI co-scientist teams launched on 6 November 2026 to accelerate experiment design.
- KisoJi’s 6 August 2026 Phase 1/2a trial expands CRUK’s commercial and clinical reach.
What critics are saying
- Gift-shop income depends on physical retail; 2025-26 shop activities raised £125.5 million.
- NCI is evaluating its CRUK partnership next; future joint funding rounds remain uncommitted.
- If research funding tightens, CRUK’s trial engine and translational pipeline lose momentum quickly.
What makes Cancer Research UK unique
- Cancer Research UK’s 2026 Centre for Drug Development sponsors first-in-human trials like KJ-103.
- Cancer Grand Challenges, co-founded with NCI, funds global teams through 2026 joint rounds.
- Cancer Research Horizons combines translational funding, licensing, spin-outs, and clinical development under one platform.
Help us improve and share your feedback! Did you find this helpful?